Mavenclad Is Merck KGaA Bright Spot As Q2 Sales Slip

 
• By Jo Shorthouse
  
Hourglass
Merck KGaA is playing the waiting game for profits to return
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip